These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Triflavin potentiates the antiplatelet activity of platelet activating factor receptor antagonist on activated neutrophil-induced platelet aggregation. Lee LW; Peng HC; Ko WC; Hung WC; Su CH; Lin CH; Huang TF; Yen MH; Sheu JR Eur J Pharmacol; 1999 Jan; 364(2-3):239-46. PubMed ID: 9932729 [TBL] [Abstract][Full Text] [Related]
3. Characterization of receptors for platelet-activating factor on platelets, polymorphonuclear leukocytes and macrophages. Stewart AG; Dusting GJ Br J Pharmacol; 1988 Aug; 94(4):1225-33. PubMed ID: 2850058 [TBL] [Abstract][Full Text] [Related]
4. Platelet-leukocyte interaction in adhesion to endothelial cells induced by platelet-activating factor in vitro. Hirafuji M; Shinoda H Br J Pharmacol; 1991 Jun; 103(2):1333-8. PubMed ID: 1884095 [TBL] [Abstract][Full Text] [Related]
5. Aggregation of human polymorphonuclear leukocytes by endothelin: role of platelet-activating factor. Gómez-Garre D; Guerra M; González E; López-Farré A; Riesco A; Caramelo C; Escanero J; Egido J Eur J Pharmacol; 1992 Dec; 224(2-3):167-72. PubMed ID: 1468506 [TBL] [Abstract][Full Text] [Related]
6. Changes in cytosolic free calcium induced by platelet-activating factor in rabbit platelets: specific inhibition by BN 52021 and structurally related compounds. Baroggi N; Etienne A; Braquet P Agents Actions Suppl; 1986; 20():87-97. PubMed ID: 3028108 [TBL] [Abstract][Full Text] [Related]
7. Mechanisms of the platelet aggregation induced by activated neutrophils and inhibitory effect of specific PAF receptor antagonists. Nguyên P; Petitfrère E; Potron G Thromb Res; 1995 Apr; 78(1):33-42. PubMed ID: 7778064 [TBL] [Abstract][Full Text] [Related]
8. Specific inhibition of PAF-acether-induced platelet activation by BN 52021 and comparison with the PAF-acether inhibitors kadsurenone and CV 3988. Nunez D; Chignard M; Korth R; Le Couedic JP; Norel X; Spinnewyn B; Braquet P; Benveniste J Eur J Pharmacol; 1986 Apr; 123(2):197-205. PubMed ID: 3086108 [TBL] [Abstract][Full Text] [Related]
10. Sensitization of human neutrophil defense activities through activation of platelet-activating factor receptors by ginkgolide B, a bioactive component of the Ginkgo biloba extract EGB 761. Lenoir M; Pedruzzi E; Rais S; Drieu K; Perianin A Biochem Pharmacol; 2002 Apr; 63(7):1241-9. PubMed ID: 11960600 [TBL] [Abstract][Full Text] [Related]
11. Inhibition of the metabolism of platelet activating factor (PAF-acether) by three specific antagonists from Ginkgo biloba. Lamant V; Mauco G; Braquet P; Chap H; Douste-Blazy L Biochem Pharmacol; 1987 Sep; 36(17):2749-52. PubMed ID: 2820421 [TBL] [Abstract][Full Text] [Related]
13. [Effect of BN52021 on platelet activating factor induced aggregation of psoriatic polymorphonuclear neutrophils]. Liu BJ; Zhang HT; Zheng MR Zhonghua Yi Xue Za Zhi; 1994 Jun; 74(6):370-2, 392. PubMed ID: 7994650 [TBL] [Abstract][Full Text] [Related]
14. Continuous binding of the PAF molecule to its receptor is necessary for the long-term aggregation of platelets. Suzuki M; Sugatani J; Ino M; Shimura M; Akiyama M; Yamazaki R; Suzuki Y; Miwa M Am J Physiol; 1998 Jan; 274(1):C47-57. PubMed ID: 9458712 [TBL] [Abstract][Full Text] [Related]
15. Biosynthesis of paf-acether factor-acether by human skin fibroblasts in vitro. Michel L; Denizot Y; Thomas Y; Jean-Louis F; Pitton C; Benveniste J; Dubertret L J Immunol; 1988 Aug; 141(3):948-53. PubMed ID: 3397536 [TBL] [Abstract][Full Text] [Related]
16. Antagonists of PAF-acether do not suppress thrombin-induced aggregation of ADP-deprived and aspirin-treated human platelets. Adnot S; Joseph D; Vargaftig BB Agents Actions; 1987 Jun; 21(1-2):195-202. PubMed ID: 3115070 [TBL] [Abstract][Full Text] [Related]
18. Short-term and long-term role of platelet activating factor as a mediator of in vivo platelet aggregation. Golino P; Ambrosio G; Ragni M; Pascucci I; Triggiani M; Oriente A; McNatt J; Buja LM; Condorelli M; Chiariello M Circulation; 1993 Sep; 88(3):1205-14. PubMed ID: 8353882 [TBL] [Abstract][Full Text] [Related]
19. Effects of platelet activating factor antagonists on arachidonic acid-induced platelet aggregation and TXA2 formation. Heinroth-Hoffmann I; Hauser A; Mest HJ Prostaglandins Leukot Essent Fatty Acids; 1990 Nov; 41(3):181-2. PubMed ID: 2149184 [TBL] [Abstract][Full Text] [Related]
20. Effect of BN 52021, a specific antagonist of platelet activating factor (PAF-acether), on calcium movements and phosphatidic acid production induced by PAF-acether in human platelets. Simon MF; Chap H; Braquet P; Douste-Blazy L Thromb Res; 1987 Feb; 45(4):299-309. PubMed ID: 3576518 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]